DK1500396T3 - Reboxetin til behandling af migrænehovedpiner - Google Patents

Reboxetin til behandling af migrænehovedpiner

Info

Publication number
DK1500396T3
DK1500396T3 DK04025514T DK04025514T DK1500396T3 DK 1500396 T3 DK1500396 T3 DK 1500396T3 DK 04025514 T DK04025514 T DK 04025514T DK 04025514 T DK04025514 T DK 04025514T DK 1500396 T3 DK1500396 T3 DK 1500396T3
Authority
DK
Denmark
Prior art keywords
reboxetine
treatment
migraine headaches
headaches
migraine
Prior art date
Application number
DK04025514T
Other languages
English (en)
Inventor
Saeeduddin Ahmed
Lars Birgerson
Pasquale Cetera
Robert Clyde Marshall
Robert Mcarthur
Duncan P Taylor
Erik H F Wong
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32831120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1500396(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Priority claimed from EP00941659A external-priority patent/EP1196172B1/en
Application granted granted Critical
Publication of DK1500396T3 publication Critical patent/DK1500396T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK04025514T 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner DK1500396T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US14413199P 1999-07-16 1999-07-16
US15825699P 1999-10-06 1999-10-06
US17038199P 1999-12-13 1999-12-13
EP00941659A EP1196172B1 (en) 1999-07-01 2000-06-22 (S,S)-Reboxetine for treating chronic pain

Publications (1)

Publication Number Publication Date
DK1500396T3 true DK1500396T3 (da) 2005-12-19

Family

ID=32831120

Family Applications (5)

Application Number Title Priority Date Filing Date
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati

Country Status (3)

Country Link
EP (10) EP1629843A3 (da)
DK (5) DK1459751T3 (da)
SI (1) SI1196172T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005256944A1 (en) * 2004-06-09 2006-01-05 Pfizer Inc. Use of reboxetine for the treatment of pain
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
AU9214498A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
EP1069900B1 (en) * 1998-04-09 2005-08-10 Pharmacia & Upjohn Company LLC Use of reboxetine for the treatment of neuropsychiatric disorders
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
EP1075264B1 (en) * 1998-05-08 2004-12-01 PHARMACIA & UPJOHN COMPANY New drug combinations of reboxetine and pindolol
AU4841599A (en) * 1998-06-29 2000-01-17 Pharmaceuticals Applications Asociates, Llc Methods and transdermal compositions for pain relief
SE9904750D0 (sv) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
CN1396829A (zh) * 2000-02-24 2003-02-12 法玛西雅厄普约翰美国公司 新的药物联合形式

Also Published As

Publication number Publication date
EP1459751A1 (en) 2004-09-22
EP1500395B1 (en) 2006-03-08
DK1500395T3 (da) 2006-06-19
EP1500396B1 (en) 2005-09-28
EP1632234A2 (en) 2006-03-08
EP1500396A1 (en) 2005-01-26
EP1632234B1 (en) 2007-06-13
EP1459749B1 (en) 2005-10-05
DK1459748T3 (da) 2005-07-04
EP1493442B1 (en) 2005-09-28
DK1493442T3 (da) 2005-12-19
EP1632235A2 (en) 2006-03-08
EP1629843A3 (en) 2006-03-15
EP1459750A1 (en) 2004-09-22
EP1459749A1 (en) 2004-09-22
EP1632234A3 (en) 2006-03-15
EP1459750B1 (en) 2005-06-01
EP1459748B8 (en) 2005-06-08
EP1629843A2 (en) 2006-03-01
EP1459751B1 (en) 2005-09-14
EP1459748A1 (en) 2004-09-22
EP1493442A1 (en) 2005-01-05
EP1632235A3 (en) 2006-06-14
EP1459748B1 (en) 2005-04-13
DK1459751T3 (da) 2005-12-19
EP1500395A1 (en) 2005-01-26
SI1196172T1 (sl) 2006-06-30

Similar Documents

Publication Publication Date Title
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DE60022917D1 (de) Reboxetin zur Behandlung von Migränekopfschmerzen
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1156813T3 (da) Reovirus til behandling af cellulære proliferative lidelser
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
AU2001272852A1 (en) Composition for the treatment of migraine
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
NO334788B2 (no) Fremgangsmåte for behandling av søvnløshet
DK1350521T3 (da) Immunoterapeutiske kombinationer til behandling af tumorer
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
DK1468996T3 (da) Indolderivater til behandling af CNS-sygdomme